MedTrace Logo

Evaluating the Effect of the Probiotic on Recurrent Urinary Tract Infection in Adult Women

NCT03366077 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 140

Last updated 2025-09-15

Study results available
· View outcomes & findings →

Summary

Urinary tract infections (UTIs) are the most common bacterial infections in women, with about 50% of women experiencing at least one UTI in their lifetime.

The main pharmacological treatments of cystitis usually involve the use of antibiotics, in particular quinolones (such as ciprofloxacin and levofloxacin), fosfomycin, second-generation and third-generation cephalosporins, and b-lactam antibiotics associated with b-lactamase inhibitors.

Conditions

  • Recurrent Urinary Tract Infection in Adult Women

Interventions

DIETARY_SUPPLEMENT

Probiotic

Probiotic

Sponsors & Collaborators

  • BioGaia AB

    lead INDUSTRY

Principal Investigators

  • Erik Rein-Hedin, MD · CTC Clinical Trial Consultants AB

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
50 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-12-13
Primary Completion
2019-07-12
Completion
2019-07-12

Countries

  • Sweden

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03366077 on ClinicalTrials.gov